The first prescription for the drug in China will reportedly be issued at a public hospital in Shanghai this week and will ...

The COVID pandemic set in motion trends with alcohol use that have persisted. Disruptions in work, school and lifestyle have ...

Novo Nordisk's blockbuster weight-loss drug Wegovy is now available for use in China, the company confirmed to AFP on Tuesday ...

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

Novo Nordisk has launched its weight-loss drug Wegovy in China after it was approved by local health authorities in June. It ...

About 140 million Americans, more than half of the nation's adults, could be considered candidates for weight loss drugs ...

Merck reported that a new formulation of Keytruda appears to deliver similar blood levels of the drug when given as a shot as ...

Novo Nordisk has launched Wegovy – its popular weight loss treatment – in China. China, with a population of 1.4 billion, has more than 180 million people living with obesity. The introduction of ...

Beijing: Novo Nordisk's blockbuster weight-loss drug Wegovy is now available for use in China, the company confirmed to AFP ...

Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.

More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...

Novo Nordisk launches its weight-loss drug Wegovy in China after approval by local health authorities in June.